Resources

Request More Information
USA / Product Areas / Vascular Access / Peripheral Access / Midline Catheters

As your partner in vascular access, Teleflex understands the challenges clinicians face. Without quick and easy identification between midlines and PICCs, clinicians may mistakenly infuse medications through midlines that should only be infused through a central venous access device. That’s why we have developed a midline portfolio designed to make the procedure and delivery of care safer.

The Arrow® Pressure Injectable Midline family features easily identifiable hubs, pinch clamps and labeling to help alleviate midline identification confusion. Choose between non-protected or our Arrowg+ard Blue Advance® Midlines, the only midline featuring antimicrobial and antithrombogenic protection.1,2

 

Arrowg+ard Blue Advance® Midline Catheter

What if your midline could reduce sources of infection and fibrin sheath accumulation post insertion?1,2

Arrow® Midline

Pressure injection capability combined with easy identification in a non-protected catheter option. Now available in ergonomic kits designed to streamline insertion and enhance workflow.

View Our Product Catalog

Want to learn more or schedule a product demo/trial?

Download our free educational and product material:

References:

  1. In vitro data on file 2010: AVER-004371 and AVER-004483. No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.
  2. As compared to uncoated PICCs, intravascular ovine model inoculated with Staph aureus: AVAR-000427. No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.

Rx only

Contraindication:

Clinical assessment of the patient must be completed to ensure no contraindications exist. The Arrowg+ard Blue Advance® Midline is contraindicated in the following areas:

  • Patients with known hypersensitivity to chlorhexidine
  • In presence of device related infections
  • In presence of previous or current thrombosis in the intended vessel or along the catheterized vessel pathway.

No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.

Teleflex, the Teleflex logo, Arrow and Arrowg+ard Blue Advance are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are trademarks of their respective owners. MC-007984 Rev 0.1